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Dear editor, Remission period: 3e5 days later, symptoms relieve. (c)The first case of imported yellow fever was confirmed on
March 12, 2016 in China, the patient was a 32-year-old man
who became ill with fever (the highest temperature is 39.3)
and chills on March 8, 2016 in Luanda, the capital of Angola,
flew to Beijing at 2 o'clock in the morning on March 10, and
straighted to the hospital. Up to March 24, 2016, there were a
total of 6 cases of imported yellow fever in our country, all
patients were from Angola.
Yellow fever, a mosquito-borne flavivirus disease occurs in
tropical areas of South America and Africa. The disease is
transmitted by blood-feeding Aedes mosquito species.
Humans usually acquire the infection accidently when bitten
by sylvatic mosquitoes that previously fed on non-human
primates (e.g., viremic monkeys), while they are visiting or
working in the jungle (so-called jungle yellow fever). On the
other hand, in the city, where relatively large population living
in close proximity to mosquito species, humans may also
serve as the viremic host for inter-human transmission by
Aedes aegypti (so-called urban yellow fever) [1].
The incubation period is usually 3e6 days, also can be up
to 10 days. Most patients infected yellow fever are asymp-
tomatic or mild symptom. Clinical disease varies from a mild,
nonspecific febrile illness to a severe acute disease with
jaundice, hemorrhage, nausea, vomiting, epigastric pain, renal
failure, severe hepatic dysfunction [1], and may lead to death,
with a case fatality rate ranging between 20% and 50% [2].
Typical clinical course can be divided into the following
four periods. (a) Infection period: this period is the viremia
stage, acute onset, lasts for 3e5 days. Patients present non-
specific symptoms, such as chills, fever (up to 39Ce41 C),
headache, dizziness, photophobia, epigastric pain, muscle
pain, anorexia, nausea, vomiting, restlessness, irritability. (b)eview under responsibility of Beijing You'an Hospital affiliated to
Medical University.
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aggravates, multiple organs damage, often involve the liver,
kidney and blood system. (d) Recovery period: the symptoms
gradually disappear during the following 2e4 weeks.
Prevention through vaccination is critical to reduce mor-
bidity and mortality from yellow fever virus infection. A
single primary dose of yellow fever vaccine is sufficient
to confer sustained immunity and lifelong protection
against yellow fever disease, and is adequate for most trav-
elers, nevertheless, risk groups, such as persons infected
with human immunodeficiency virus (HIV) or infants,
who might benefit from a booster dose [3e5]. Because no
curative treatment is available, only supportive care can be
provided.
Preventive measures include the following three aspects.
First, control the source of infection. For suspected and
confirmed case, effective anti-mosquito and isolation meas-
ures should be taken. Screening of febrile returning travelers
from infected area is highly advised. Possible further control
measures include Yellow fever infection and the timely
notification of public health authorities. The role of clinicians
is crucial and includes early diagnosis and timely notification
of public health authorities in order to quickly implement
adequate control measurements. Second, cut off the route of
transmission. Anti-mosquito, killing mosquito (spraying adult
mosquitoes and destruction of larval breeding sites) is an
important prevention and control measure. Adequate public
health preventive measures, such as, public education and
mosquito bite prevention, should be implemented quickly
after the diagnosis of an imported case. Third, protect vul-
nerable groups. People should get Yellow fever vaccination at
least 10 days before they leave for the endemic area, and take
personal anti-mosquito measures.. Production and hosting by Elsevier B.V. This is an open access article under
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